Literature DB >> 30535832

Complete remission of pure white cell aplasia associated with thymoma after thymectomy and cyclosporine administration.

Yuji Kobayashi1, Koji Ando2, Tomoko Hata3, Yoshitaka Imaizumi4, Kazuhiro Nagai4, Rena Kamijyo5, Takeharu Katoh1, Jun Taguchi6, Hidehiro Itonaga4, Shinya Sato4, Yasushi Sawayama4, Yasushi Miyazaki3,4.   

Abstract

We present the case of a 63-year-old male with pure white cell aplasia (PWCA), a rare complication of thymoma, who was successfully treated with cyclosporine A (CyA) and thymectomy. The patient presented with high fever and agranulocytosis. Complete blood count revealed a white blood cell count of 0.9 × 109/L (3% neutrophils), a hemoglobin level of 15.8 g/dL, and a platelet count of 308 × 109/L. Bone marrow (BM) aspiration revealed a hypocellular marrow lacking granulocytes. Computed tomography showed a large anterior mediastinal mass, and the patient was diagnosed with PWCA associated with thymoma. Thirteen days after the initiation of CyA treatment, myeloid cells appeared in the BM, and the neutrophil count in peripheral blood started to increase on day 18. Thymectomy was performed 3 months later. Although CyA treatment was discontinued after thymectomy, complete remission has been maintained for over 4 years. In vitro colony-forming unit granulocyte-macrophage (CFU-GM) assay using the patient's serum showed severe suppression of CFU-GM colonies in the presence of the patient's serum, suggesting the presence of CFU-GM inhibitor in the patient's serum. The efficacy of the immunosuppressive therapy and the CFU-GM assay suggests the potential involvement of an immunological mechanism in patients with thymoma-associated PWCA.

Entities:  

Keywords:  Cyclosporine; Pure white cell aplasia; Thymectomy; Thymoma

Mesh:

Substances:

Year:  2018        PMID: 30535832     DOI: 10.1007/s12185-018-02573-y

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  3 in total

Review 1.  Paraneoplastic and Therapy-Related Immune Complications in Thymic Malignancies.

Authors:  Elizabeth A Lippner; David B Lewis; William H Robinson; Tamiko R Katsumoto
Journal:  Curr Treat Options Oncol       Date:  2019-06-22

2.  Clinical efficacy of thoracoscopic surgery by subxiphoid approach for thymoma and its influence on intraoperative blood loss and postoperative complications.

Authors:  Peng Shen; Quan Chen; Fengwei Zhu; Shouqi Tang; Xuxian Zhang; Feng Li
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

3.  Pure White Cell Aplasia and Immune Thrombocytopenia after Thymoma Resection: A Case Report and Review of the Literature.

Authors:  Michael Youssef; Tyler W Stratton; Reid C Gallant; Christine Young; Daniel Y Li; Siavash Piran
Journal:  Case Rep Hematol       Date:  2022-03-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.